Proteins exported from Plasmodium falciparum parasites into red blood cells (RBCs) interact with the membrane skeleton and contribute to the pathogenesis of malaria. Specifically, exported proteins increase RBC membrane rigidity, decrease deformability and increase adhesiveness, culminating in intravascular sequestration of infected RBCs (iRBCs). Pf332 is the largest (> 1 MDa) known malaria protein exported to the RBC membrane but its function has not previously been determined. To determine the role of Pf332 in iRBCs, we have engineered and analysed transgenic parasites with Pf332 either deleted or truncated. When compared to RBCs infected with wild-type parasites, mutants lacking Pf332 were consistently more rigid, significantly less adhesive to CD36 and showed decreased expression of the major cytoadherence ligand, PfEMP1, on the iRBC surface. These abnormalities were associated with quantitative and dramatic morphological changes in Maurer's clefts (MCs); membrane structures that transport malaria proteins to the RBC membrane. In contrast, RBCs infected with parasites expressing truncated forms of Pf332, while still hyper-rigid, showed a normal adhesion profile and morphologically-normal MCs. Our results suggest that Pf332 both modulates the level of increased RBC rigidity induced by P. falciparum and plays a significant role in adhesion by assisting transport of PfEMP1 to the iRBC surface.
Introduction
A key feature in the pathogenesis of falciparum malaria is the parasite's ability to perturb the normal rheological properties of the red blood cells (RBCs) that they invade. RBCs infected with mature stages of Plasmodium falciparum (iRBCs) are poorly deformable and adhere to the vascular endothelium. This grossly abnormal circulatory behaviour results in the accumulation of iRBCs within the spleen and the microvasulature leading to life-threatening complications such as severe anemia and cerebral malaria 1, 2 .
At the molecular level, these RBC modifications are mediated by a subset of parasite proteins that are exported across the parasitophorous vacuole membrane (PVM) into the RBC where they then associate specifically with components of the RBC membrane skeleton. Many of these proteins carry a pentameric host targeting signal sequence (termed vacuolar transport signal (VTS) or Plasmodium export element (PEXEL)) and are trafficked via parasite induced membranous structures within the iRBC termed Maurer's clefts (MCs) [3] [4] [5] . P.
falciparum erythrocyte membrane protein 1 (PfEMP1) is the major adhesion ligand that is exposed on the iRBC surface that can bind to a number of receptors expressed on vascular endothelial cells, including CD36 1 .
Other proteins, such as the knob-associated histidine rich protein (KAHRP), mature parasite-infected erythrocyte surface antigen (MESA) and PfEMP3, are localised on the cytosolic side of the iRBC membrane. By forming specific protein-protein interactions with components of the RBC membrane skeleton, they anchor PfEMP1 into the RBC membrane and alter the mechanical properties of iRBCs [6] [7] [8] .
Plasmodium falciparum antigen 332 (Pf332) is encoded by a gene of ~20kb and is the second largest protein in the P. falciparum proteome with an observed molecular mass of > 1MDa 9 .
It is composed of a Duffy binding-like (DBL) domain at the N-terminus of the protein and a large number of highly degenerate glutamic acid-rich repeats in the C-terminal domain 10 .
During the early stages of parasite development, Pf332 is localised at the PVM and in MCs, and in later stages also associates with the iRBC membrane skeleton 9, 11 . To date, few studies have focused on Pf332 and its function within iRBCs remains unknown. It has been suggested that Pf332 is partially exposed on the surface of iRBCs and anti-Pf332 antibodies have been shown to inhibit both parasite growth and cytoadherence in vitro 9, 10, 12, 13 . However, localization studies of RBCs containing very mature parasites are known to be problematic as increased permeability of the RBC membrane can allow antibodies access to parasite proteins on the cytoplasmic face of the membrane 11 and this may in fact explain how anti-Pf332
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In an attempt to determine the function of Pf332 in iRBCs, we have created a number of independent transgenic parasite lines in which the Pf332 gene was either deleted or truncated.
Interestingly, Pf332 appears to have a dual function in iRBCs, regulating both the extent of parasite-induced membrane rigidification and the cells' adhesive properties. Our data identifies Pf332 as an important player in the modification of RBCs and ultimately the pathogenesis of falciparum malaria.
Materials and methods

Malaria parasites
P. falciparum parasites (3D7 clone) were maintained in continuous in vitro culture in human RBCs suspended in HEPES-buffered RPMI 1640 medium supplemented with 0.5% AlbumaxII using standard procedures 14 . Cultures were kept synchronous, and the knobpositive phenotype maintained by weekly flotation in gelatin as previously described 15 .
Clonal parasite lines were derived from transfected 3D7 parasite lines by limiting dilution ( Figure S1 ).
Plasmid constructs
To disrupt the Pf332 gene in 3D7 parasites, two ~1 kb sequences from the 5' end of exon 1 of Pf332 were cloned into the P. falciparum transfection plasmid pHHT-TK 16 (a gift from Profs.
A. Cowman and B. Crabb, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia) to derive pHTKΔ332 ( Figure 1A) . Specifically, the first segment of Pf332 was amplified from genomic DNA from 3D7 parasites using forward and reverse primers 5'TCCCCGCGGgaatctgtctaatataaataactaaga3' (SacII site underlined) and 5'GGACTAGTctatgaaatttatctactaat3' (SpeI site underlined) respectively, and subcloned into the SacII and SpeI sites of pHHT-TK upstream of the human dihydrofolate reductase (hdhfr) drug resistance cassette. The second segment, located 40 bp downstream of the first, was amplified using forward and reverse primers 5'CCATCGATgatgaattaaatcgtgataat3' (ClaI site underlined) and 5'CATGCCATGGcattattttttctatttcgttct3' (NcoI site underlined) respectively, and introduced into the ClaI and NcoI sites downstream of hdhfr.
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To disrupt the Pf332 gene to allow for the expression of a truncated Pf332 protein product, two slightly overlapping regions of ~1kb were cloned separately into the XhoI site of the P. falciparum transfection plasmid pHC1 17 to derive pHC1-332Δa and pHC1-332Δb respectively ( Figure 1B ). The target sequences for pHC1-332Δa and pHC1-332Δb were amplified from 3D7 genomic DNA using forward and reverse primers 5'CCGCTCGAGacgaattccggaacaagaagg3' and 5'CCGCTCGAGctcagcatctgattctttgtttat3', and 5'CCGCTCGAGgttcaagatggattaattaca3' and 5'CCGCTCGAGagtaagtgatttttcgtcaat3'
(restriction sites underlined) for a and b respectively, and introduced into the XhoI site flanked by the calmodulin (CAM 5') promoter and the heat-shock protein 86 (HSP86 3') terminator sequences. Both inserts were in the forward orientation with respect to the drug resistance cassette.
Parasite transfection
Ring-stage parasites were transfected with 150μg plasmid DNA by electroporation as described previously 18 . For targeted gene knockout (KO), parasites transformed with pHTKΔ332 were cultured in the presence of 2.5nM WR99210 for approximately 30 days until viable parasites were observed in blood smears stained with Giemsa. Ganciclovir (4μM;
Roche Diagnostics) was then added to select for parasites having only double crossover homologous recombination 16 . For truncation of Pf332, positive selection for parasites transformed with pHC1-Pf332Δa/b was performed using 0.1μM pyrimethamine (SigmaAldrich) initially as previously described 19 . The concentration of pyrimethamine was then increased to 1μM following drug cycling.
DNA extraction and Southern blotting
Genomic DNA was extracted from parasite culture using the Nucleon BACC2 kit (GE Healthcare), digested with XbaI, separated on 1% agarose gels and transferred to nylon membrane. Southern blot hybridization and analysis was performed using standard procedures.
Western blotting
Cultured iRBCs were harvested on Percoll and membrane proteins were extracted using Triton X-100 and SDS solubilization as described previously and diluted in reducing Laemmli sample buffer. Total parasite extracts were then separated on 5% SDS-PAGE gels 
Indirect immunofluorescence assays
Indirect immunofluorescence was conducted either on thin culture smears that had been air dried and fixed with cold acetone/methanol (9:1), or on cultured iRBCs that had been fixed with paraformaldehyde then permeabilized with equinatoxin II 20 in suspension as recently 
Electron microscopy
To examine the ultrastructure of MC's by electron microscopy, RBCs from cultures containing predominantly mature-stage parasites were fixed, stained and sectioned using routine preparative techniques as previously described 22 . Briefly, cultured RBCs were fixed with glutaraldehyde, post-fixed with osmium tetroxide then stained 'en-bloc' with uranyl acetate prior to embedding in LR White resin. After sectioning, samples were stained with uranyl acetate and lead citrate and observed using a JEOL 2010HC electron microscope at 80 kV. Digital images were captured using a Veleta (2k x 2k) side-mounted TEM camera (Olympus Soft Imaging System (Munster, Germany).
Measurement of membrane shear elastic modulus by micropipette aspiration
Single cell micropipette aspiration was used to determine the shear elastic modulus of RBC membranes as previously described 7 . Briefly, the membrane of individual RBCs was aspirated progressively into pre-fabricated glass micropipettes (internal diameter 1.2 - 
Measurement of RBC adhesive properties
Adhesion of iRBCs to CD36, either purified or expressed on the surface of platelets was quantified under both static and flow conditions. Parasite cultures were tested when the majority of parasites were pigmented trophozoites as assessed by Giemsa-stained smears. In platelet monolayers using a flow-control system as previously described 25, 26 . Adherent iRBCs were visualised and quantified by direct microscopic observation (IMT-2; Olympus) with a 40x water immersion objective (Olympus) and the relative proportions of adherent iRBCs infected with either parental 3D7 parasites or a transgenic clonal line determined.
Analysis of PfEMP1 on the surface of iRBCs by trypsin cleavage assay
Trypsin cleavage assays were performed to detect PfEMP1 expressed on the surface of iRBCs as previously described 27 . Briefly, mature iRBCs were enriched on Percoll then
For personal use only. on . by guest www.bloodjournal.org From 8 incubated with 100µg/ml TPCK-treated trypsin (Sigma-Aldrich) in the presence or absence of 1mg/ml soybean trypsin inhibitor (STI; Sigma-Aldrich) for 15 min at 37 o C. Trypsin activity was then ablated by the addition of STI to a final concentration of 1mg/ml followed by a further incubation at room temperature for 15 min. RBC membrane skeleton-associated proteins (including PfEMP1) were extracted using Triton X-100 and SDS solubilisation as described previously and diluted in reducing Laemmli sample buffer 27 . Samples were separated on 6% SDS-PAGE gels and transferred for 4 h at 4 o C onto PVDF. The cytoplasmic tail of PfEMP1 (VARC) was detected using mouse monoclonal antibody 1B/98-6H1-1
(1:100; The Walter and Eliza Hall Institute Monoclonal Antibody Facility, Bundoora, Victoria, Australia).
Results
Disruption of the Pf332 locus and generation of mutant parasite clones
Pf332 (PlasmoDB gene identification number PF11_0507) is approximately 20kb in length and is located in the sub-telomeric region of P. falciparum chromosome 11. To investigate the role of Pf332 in the structural and functional modification of iRBCs we generated stable transgenic P. falciparum clones (from the 3D7 parasite clone) in which Pf332 was disrupted ( Figure S1 ). Integration of the hdhfr drug cassette into Pf332 by double cross-over homologous recombination disrupted the coding region at residue 341, resulting in loss of the majority of the Pf332 coding sequence ( Figure 1A ). Four clonal lines (11G7, 12F3, 13E2 and 13F7) from two independent transfection events were obtained by limiting dilution ( Figure   S1 ). Analysis by Southern blotting of genomic DNA digested with BamHI and probed with either Pf332-F2 or hdhfr confirmed that Pf332 had been disrupted in all four parasite clones ( Figure 1A ,C). Similar results were obtained on Southern blots using genomic DNA digested with XbaI (data not shown). Since our KO strategy had interrupted the coding region of
Pf332 at residue 341, we performed RT-PCR to rule out the possibility that the first ~35kDa
of Pf332 was expressed in the KO clones. cDNA from parental 3D7 parasites and all four KO clones, generated using a Pf332 specific primer or oligo-dT respectively, was subjected to PCR using primers specific for the extreme 5' end of the Pf332 gene. No PCR product was detected for any of the KO mutants, while a product of the expected size was observed for 3D7 ( Figure S2 ). This confirmed that Pf332 transcription was completely ablated in the KO parasite lines. No episomal plasmid could be detected in any of the clones by PCR analysis (data not shown).
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We also generated transgenic parasite lines in which Pf332 was truncated. This strategy was designed so that integration of either pHC1-332Δa or pHC1-332Δb into Pf332 by single cross-over homologous recombination would disrupt the coding region at residues 2965 and 3246 respectively ( Figure 1B) . Following drug cycling to eliminate episomal plasmid and cloning by limiting dilution, two clones for each construct (3F3 and 12H9 for pHC1-332Δa; and 5G1 and 13F5 for pHC1-332Δb) were selected ( Figure S1B ). Southern blotting ( Figure   1B and 1D) and PCR analysis (data not shown) confirmed that integration had occurred as expected.
Characterization of Pf332 deletion and truncation mutant parasites
The transgenic parasite clones were analysed for Pf332 expression by Western blotting using polyclonal antibodies raised against the extreme NH 2 -terminal region of Pf332 (Figure 2A ).
In RBCs infected with parental 3D7 parasites, Pf332 was detected as a high molecular weight band migrating well above the 250 kDa marker. A number of smaller bands were also observed which are likely to be processed or proteolytic break down products of the fulllength protein as they were not detected in the KO lines. As expected, all four KO clones showed no reactivity of any bands with the Pf332 antibody, confirming that Pf332 expression had been completely ablated. In each of the truncated clones, a partial, smaller Pf332 protein was observed that also migrated above the 250kDa marker but below full length Pf332. As expected, clones 3F3 and 12H9 expressed a smaller protein product than clones 5G1 and 13F5. Densitometric quantitation of total Pf332 reactivity from 3D7 and each of the truncation mutants revealed that all mutants expressed similar, yet reduced levels of the truncated Pf332 protein. When adjusted for differences in loading between parasite samples, using reactivity of P. falciparum heat shock protein 70 (HSP70) as a loading control, the mean level of truncated Pf332 expressed in all mutants was 44% of the level of full-length protein expressed by 3D7 parasites (range 39% -53%) (Figure 2 ). Pf332 KO parasites by electron microscopy revealed the ultrastructural basis for this unusual MC phenotype. In the absence of Pf332, MCs underlying the RBC membrane were highly aggregated and formed multi-lamellar stacks rather than individual lamellae that are displayed by wild-type 3D7 parasites ( Figure 3B ).
Pf332 modulates parasite induced rigidification of the iRBC membrane
To determine the contribution of Pf332 to the altered mechanical properties of the RBC membrane skeleton, we measured and compared the shear elastic modulus of normal uninfected RBCs and RBCs infected with either parental 3D7 parasites or transgenic parasite lines ( Figure 4 ). As expected, infection of RBCs with 3D7 parasites caused a significant increase in the rigidity of the RBC membrane (P < 0.0001 by one way ANOVA) and on average, the elastic modulus of 3D7 iRBCs was 2.6 times higher than that of uninfected RBCs. Notably, the elastic modulus of RBCs infected with either the Pf332 truncation or KO mutants was even higher than that of 3D7 iRBCs, with an average increase of 3.2 and 3.4
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Pf332 KO parasites demonstrate reduced adhesion under static and flow conditions
Cytoadherence of iRBCs to the vascular endothelium is dependent upon correct presentation 
Trafficking of PfEMP1 to the iRBC surface is reduced in Pf332 KO parasites
To investigate whether reduced adhesion of Pf332 KO iRBCs was due to a reduction in the amount of PfEMP1 exposed on the iRBC surface, trypsin cleavage assays were performed ( Figure 6 ) 27 . Since RBCs infected with Pf332 truncated parasite lines showed normal levels of adhesion, they were not analysed by this method. Trypsin treatment of intact iRBCs results in proteolysis of the exodomain of PfEMP1, leaving intact the ~80kDa cytoplasmic tail (VARC) which can be detected with a VARC-specific antibody. Western blot analysis of trypsin treated iRBCs was conducted three times. In each case surface exposed PfEMP1 was shown to be reduced as evidenced by the absence or reduction of the 80kDa trypsin-resistant cytoplasmic tail of PfEMP1 in the KO lines as compared to the parental control ( Figure 6 ).
Immunofluorescence analysis of Pf332 KO iRBCs using the anti-VARC antibody revealed that PfEMP1 was still localised in MCs and its intracellular distribution did not appear
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Discussion
As P. falciparum malaria parasites develop and mature, they progressively modify the unique rheological properties of the RBCs in which they reside. iRBCs are poorly deformable, highly rigid and show an abnormal propensity to adhere to vascular endothelial cells. . Our data does not support this, but rather suggests that the DBL domain is not externally exposed on the RBC. We base this on localization studies using antibodies raised against the extreme N-terminus of Pf332 (containing the DBL domain) in either intact or permeabilized iRBC, which place the protein at the MCs, within the RBC cytoplasm, and not at the RBC surface. We have also attempted to directly observe Pf332 on the RBC surface both by live IFA using the N-terminal directed antibody and by immunoblotting for a protease sensitive fragment of Pf332 which would be cleaved following treatment of intact iRBCs with trypsin. In neither experiment could we detect any externally exposed Pf332 leading us to conclude that there is very little or none exposed on the RBC surface (data not
shown). We postulate that the DBL domain of Pf332 is likely to be found in the interior of the MC and is acting as some form of protein association domain, perhaps with specific domains of PfEMP1. Thus the defect in adhesion in Pf332 null parasites may be due to diminished trafficking of PfEMP1 to the surface because it is incorrectly stabilised within the lumen of the MCs. Alternatively, the abnormal morphology and location of the MC may make it more difficult for PfEMP1 to exit correctly and translocate onto the RBC surface.
This was the likely mechanism of loss of adhesion by SBP1 null parasites in which the absence of SBP1 prevented docking of MCs to the RBC membrane skeleton with consequent effects on PfEMP1 translocation onto the RBC surface 27 . Finally, neither do we believe that the reduced ability of Pf332 KO iRBCs to adhere could be the result of a possible var gene switching event during the parasite derivation or cloning process and consequent expression of a different surface PfEMP1 with altered affinity for CD36. First, almost all var genes encode PfEMP1 that bind to CD36 (the adhesion assay we performed) so that switching would be unlikely to affect the measurement. Most compelling, however, is the observation that all four independent KO clones showed reduced adhesion and all four independent truncation mutants adhered at wild type levels, suggesting that only complete loss of the gene would lead to decreased adherence (P<0.03 by Fisher's exact test).
The role of Pf332 in the maintenance of normal MC morphology is intriguing. It is possible that the large (5533 residue), highly negatively charged (pI = 3.79) cytoplasmic domain of Pf332 may play a role in separating MCs as they are formed, so in the absence of Pf332, MCs aggregate into multi-lamellar stacks. Consistent with this hypothesis is our observation that in the truncation mutants that have a reduced yet still highly charged cytoplasmic domain (pI ~3.70) almost identical to that for the full length protein (3.79), MCs do not aggregate and exhibit normal, wild-type single lamellae morphology. However, very little is known about the process of MC budding, formation or maturation and more information is required before a detailed mechanism can be suggested.
In contrast to other exported parasite proteins, whose role in the alteration of the mechanical properties of the infected RBC is to increase membrane rigidity, Pf332 is the first protein to 
